TSLIG3A and endothelial dysfunction: FAM98A, harboring multiple arginine demethylation sites, is a substrate of PRMT1 - an enzyme which catalyzes the synthesis of asymmetric dimethylarginine (ADMA), a molecule associated with cardiovascular harm as it induces endothelial dysfunction(49).